Academe Learn
CBME Curriculum Preview

Page 8 of 8

CM18.1-3 | International Health — PBL Case

CLINICAL SETTING

Rajiv Kumar, a 34-year-old poultry farm supervisor from Amritsar, returns from a 10-day work visit to a live-bird market in Guangdong Province, China. Six days after returning, he develops high fever (39.8°C), dry cough, and progressive breathlessness. His wife rushes him to a district hospital where a chest X-ray shows bilateral infiltrates. The treating physician — Dr Priya Sharma — notes that his SpO₂ is 88% on room air and recalls reading a WHO risk assessment from two months ago flagging an unusual cluster of severe respiratory illness among poultry handlers in South China. Rajiv's travel history makes Dr Sharma pause. She calls the state's IDSP nodal officer.

Trigger 1: Initial Presentation — Is This Just Pneumonia?

Dr Sharma reviews Rajiv's details: poultry farm supervisor, returned from a live-bird market in Guangdong 6 days ago, now with fever, cough, bilateral chest infiltrates, SpO₂ 88%. She contacts the state IDSP officer, who flags it as a 'respiratory illness of unknown aetiology with international travel history'. A nasopharyngeal swab is collected and sent to a state lab. The district hospital's isolation room has two beds. Rajiv's 7-year-old daughter visited him yesterday and today has a mild fever.

DISCUSSION POINTS

  • What makes this case a potential international health event rather than routine community-acquired pneumonia?
  • Which features of the clinical and epidemiological picture are most concerning for a novel zoonotic pathogen?
  • What immediate steps should Dr Sharma and the IDSP officer take in the next 2 hours?
  • Define 'emerging infectious disease' and 're-emerging infectious disease' — which category might this case fall into, and why does the distinction matter for agency response?
Click to reveal Trigger 2: The Notification Decision — Who Calls Whom? (discuss previous trigger first!)

Trigger 2: The Notification Decision — Who Calls Whom?

The state lab detects influenza A antigen but standard H1N1/H3N2 subtypes are negative. The sample is sent to NCDC, New Delhi for advanced characterisation. Simultaneously, NCDC's early warning desk notes that Guangdong Province has reported 9 cases of 'atypical avian influenza' in the past 3 weeks — not yet confirmed H5N1 but under investigation by China's CDC. The WHO China Country Office has been notified by China under IHR 2005 and has posted a Disease Outbreak News update. The NCDC Medical Officer must now decide: does India need to notify WHO? Rajiv's condition deteriorates and he requires ICU-level care. His daughter's swab is positive for the same influenza A antigen.

DISCUSSION POINTS

  • Apply the IHR 2005 Annex 2 decision instrument to Rajiv's case. Which of the four criteria are met? Does India have a notification obligation?
  • Who specifically does India notify, and through what channel? How soon after identification?
  • What role does WHO SEARO play at this stage versus WHO Headquarters Geneva?
  • If a PHEIC is subsequently declared, what are the legal consequences for India and for international travellers?
Click to reveal Trigger 3: Coordinated International Response — Who Does What? (discuss previous trigger first!)

Trigger 3: Coordinated International Response — Who Does What?

NCDC confirms a novel avian influenza A (H5N2) in Rajiv and his daughter — the first human cases outside China. India formally notifies WHO via the National IHR Focal Point. WHO convenes an Emergency Committee under IHR 2005 within 48 hours. Three more cases — all contacts of Rajiv — are identified in Amritsar. WHO declares a PHEIC. The Global Outbreak Alert and Response Network (GOARN) deploys a Rapid Response Team. UNICEF activates its supply chain for PPE to the district hospital. The World Bank commits emergency financing to strengthen ICU capacity. Dr Priya Sharma is invited to present at a WHO technical consultation as the clinician who identified the index case.

DISCUSSION POINTS

  • For each agency involved (WHO, UNICEF, World Bank, GOARN), describe the specific action taken and the mandate authority that justifies that action.
  • What Temporary Recommendations might WHO issue to India and to all other countries? Should travel bans be imposed — what does IHR 2005 actually say?
  • How does India contribute to the global response (vaccine manufacturing capacity, pharmaceutical supply, technical expertise)?
  • Critically evaluate: what aspects of India's international health architecture worked well in this case? What gaps were exposed? How might they be addressed?

Group Task Assignments

Group 1: WHO and IHR 2005 — Legal Framework

  • Map the IHR 2005 notification process from district hospital to WHO Geneva: every step, every actor, every timeframe
  • Identify the 3 criteria for PHEIC declaration and explain how each is met or not met in this case
  • Summarise what Temporary Recommendations WHO may and may not issue under IHR 2005 (including why outright travel bans are legally problematic)

Competencies: CM18.3

Group 2: UNICEF and World Bank — Operational Response

  • Describe UNICEF's mandate and its operational role in outbreak response (PPE, WASH, risk communication, child protection)
  • Describe the World Bank's health financing mechanisms (IDA, Health Emergency Preparedness Fund) and how emergency funds are accessed
  • Identify where each agency's accountability lies and how their performance is evaluated

Competencies: CM18.2

Group 3: India's Role — Dual Contributor and Recipient

  • Map India's pharmaceutical and vaccine manufacturing contribution to global outbreak response (Serum Institute, Biological E, Bharat Biotech)
  • Identify India's IHR core capacities: which are certified as adequate? Which remain gaps per Joint External Evaluation (JEE) reports?
  • Propose two improvements to India's international health architecture based on this case

Competencies: CM18.1, CM18.2, CM18.3

Group 4: One Health and Determinants — Preventing the Next Case

  • Analyse the ecological and social determinants that led to Rajiv's exposure (live-bird markets, poultry industry, international labour migration)
  • Describe India's One Health surveillance framework: which agencies participate, what do they monitor, what are the detection gaps?
  • Propose a One Health intervention package that could have detected this novel H5N2 before human cases

Competencies: CM18.3

Group 5: SDGs, Global Health Equity, and International Health Inequity

  • Identify which SDG targets are most relevant to preventing this type of outbreak (SDG 3, SDG 6, SDG 15) and explain the linkage
  • Analyse how health inequity between high-income and lower-income countries affects both outbreak risk and response capacity
  • Evaluate whether the current international health architecture adequately protects all countries — what structural reforms have been proposed post-COVID-19?

Competencies: CM18.1, CM18.2

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [CM18.1] What is international health? How does it differ from global health and from domestic public health? What are the main determinants that create international health inequity?
  2. [CM18.2] What are the mandates, headquarters locations, and specific health roles of WHO, UNICEF, World Bank, UNDP, Gavi, and GOARN? How do they coordinate during a PHEIC?
  3. [CM18.3] What is IHR 2005? What are its core notification criteria, how is PHEIC declared, and what are its legal consequences? What is NCDC's role as India's National IHR Focal Point? How does India prevent, detect, and respond to pandemic threats?